An SG - Search Results

1

[Analyses of chromosomal karyotypes and cytogenetic variations of animal cell lines].

Zhang DL, Li LJ, Xia GT, He XY, Gao BX, Bai XH, Huang GS, Liu SG, Yan LF, Fang FD, Hu CL, Wang LJ, Jiang HH, Feng AM, Zhang GM, An SG, Ren YQ, Guo JM, Hu SX, Fan JX, Niu YL, Song ZJ, Li Y, Fan SJ. Zhang DL, et al. Among authors: an sg. Yi Chuan Xue Bao. 2001;28(4):327-44. Yi Chuan Xue Bao. 2001. PMID: 11329875 Chinese.

2

ImmunoPET imaging of multiple myeloma with [⁶⁸Ga]Ga-NOTA-Nb1053.

Wang C, Chen Y, Hou YN, Liu Q, Zhang D, Zhao H, Zhang Y, An S, Li L, Hou J, Huang G, Liu J, Zhao YJ, Wei W. Wang C, et al. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2749-2760. doi: 10.1007/s00259-021-05218-1. Epub 2021 Feb 5. Eur J Nucl Med Mol Imaging. 2021. PMID: 33543326

3

¹⁸F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma.

An S, Zhou X, Liu J, Huang G. An S, et al. Onco Targets Ther. 2017 Nov 27;10:5643-5651. doi: 10.2147/OTT.S150334. eCollection 2017. Onco Targets Ther. 2017. PMID: 29225472 Free PMC article.

4

Annotating BCMA Expression in Multiple Myelomas.

Wei W, Zhang Y, Zhang D, Liu Q, An S, Chen Y, Huang G, Liu J. Wei W, et al. Mol Pharm. 2022 Oct 3;19(10):3492-3501. doi: 10.1021/acs.molpharmaceut.1c00628. Epub 2021 Nov 29. Mol Pharm. 2022. PMID: 34843261

5

Annotating CD38 Expression in Multiple Myeloma with [¹⁸F]F-Nb1053.

Wei W, Zhang D, Wang C, Zhang Y, An S, Chen Y, Huang G, Liu J. Wei W, et al. Mol Pharm. 2022 Oct 3;19(10):3502-3510. doi: 10.1021/acs.molpharmaceut.1c00733. Epub 2021 Nov 30. Mol Pharm. 2022. PMID: 34846151

6

GPC3-targeted immunoPET imaging of hepatocellular carcinomas.

An S, Zhang D, Zhang Y, Wang C, Shi L, Wei W, Huang G, Liu J. An S, et al. Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2682-2692. doi: 10.1007/s00259-022-05723-x. Epub 2022 Feb 11. Eur J Nucl Med Mol Imaging. 2022. PMID: 35147737

7

PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers.

An S, Huang G, Liu J, Wei W. An S, et al. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):3973-3976. doi: 10.1007/s00259-022-05905-7. Eur J Nucl Med Mol Imaging. 2022. PMID: 35916921 No abstract available.

8

Development and comparison of ⁶⁸Ga/¹⁸F/⁶⁴Cu-labeled nanobody tracers probing Claudin18.2.

Wei W, Zhang D, Zhang Y, Li L, Jin Y, An S, Lv C, Zhao H, Wang C, Huang Y, Dong J, Huang G, Liu J. Wei W, et al. Mol Ther Oncolytics. 2022 Nov 14;27:305-314. doi: 10.1016/j.omto.2022.11.003. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36570796 Free PMC article.

9

PET imaging of tumor vascular normalization in hepatocellular carcinoma.

An S, Liu J, Huang G, Kang F, Wei W. An S, et al. Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):2940-2943. doi: 10.1007/s00259-023-06337-7. Eur J Nucl Med Mol Imaging. 2023. PMID: 37458760 No abstract available.

10

ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers.

Huang W, Liang C, Zhang Y, Zhang D, An S, Wu Q, Li J, Zhao H, Wang C, Cui J, Bao Z, Huang G, Wei W, Liu J. Huang W, et al. Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):380-394. doi: 10.1007/s00259-023-06454-3. Epub 2023 Oct 4. Eur J Nucl Med Mol Imaging. 2024. PMID: 37792026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page